Content about Health

FAIR LAWN, N.J. Brioschi Pharmaceuticals International last month announced its intent to revitalize the Brioschi heartburn-relief brand. The company is pitting substantial capital into a marketing plan that incorporates everything from trade promotions, sampling and healthcare professional recommendations to newspaper advertising, digital marketing and sponsorships, the company stated.

CHADDS FORD, Pa. Strong generic sales helped Endo edge analyst expectations for the third quarter, the company noted.

Net income reached $54.2 million, compared with $49.4 million during the period ended Sept. 30. Net sales jumped 23% to $444.1 million, versus $361 million during the same period a year ago. Analysts had estimated sales of $443.36 million for the quarter.

FRANKLIN LAKES, N.J. Pharmacy benefit manager Medco Health Solutions had sales of $16.3 billion, including $2.9 billion from specialty pharmacy operations, the company said Tuesday.

FORT WORTH, Texas Retail pharmacy technology provider PDX has partnered with Healthcare Data Solutions to provide users of the PDX Pharmacy System with access to a real-time prescriber verification process.

The companies said the integration of the PDX Pharmacy System and the HDS ProscriberPRO database would allow immediate verification of prescribers and associated profiles when a prescriber is added or before a prescription is filled, with access provided over a secure, Web-based service.

IRVINGTON, N.Y. Prestige Brands Holdings on Monday announced that it has completed its previously announced purchase of Blacksmith Brands Holdings.

The transaction was finalized under the original terms announced on Sept. 20, which called for Prestige to pay $190 million in cash at closing plus a customary working capital adjustment that amounted to $13.4 million.

ROCHESTER, N.Y. Wegmans on Monday announced the availability of its co-branded blood-glucose monitoring systems: Nipro Diagnostics’ TrueResult system and True2go.

CONSHOHOCKEN, Pa. Up to 1-in-4 emergency room visits could take place at a retail-based health clinic or urgent care center, saving potentially $4.4 billion annually, according to new research published in the September issue of Health Affairs.

Furthermore, the research found that such retail clinics as Take Care Clinics have been shown to save patients $279 to $460 per visit compared with emergency room costs.

SILVER SPRING , Md. (Oct. 29) The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency said Thursday.

The FDA announced the approval of Latuda (lurasidone hydrochloride), made by Fort Lee, N.J.-based Sunovion Pharmaceuticals. The drug is approved to treat adults with the disease, a mental illness that causes hallucinations, delusions, paranoia and disordered thinking and behavior.